Early Trial Finds Personalised Cancer Vaccine Feasible for PatientsEilidh CampbellOctober 16, 20260 A phase 1 trial of the personalised NeoVax vaccine with nivolumab in ovarian cancer found the approach feasible with acceptable safety. Here is what it means.
